Cenzo PharmaTamoxifen binds to ER competitively (with respect towards the endogenous agonist estrogen) in tumor cells along with other tissue targets, making a nuclear intricate that decreases DNA synthesis and inhibits estrogen results. This is a nonsteroidal agent with powerful antiestrogenic Attributes which compete with estrogen for binding int